243 related articles for article (PubMed ID: 15758133)
1. Cross-species pharmacologic evaluation of plasmin as a direct-acting thrombolytic agent: ex vivo evaluation for large animal model development.
Landskroner K; Olson N; Jesmok G
J Vasc Interv Radiol; 2005 Mar; 16(3):369-77. PubMed ID: 15758133
[TBL] [Abstract][Full Text] [Related]
2. Direct microscopic monitoring of initial and dynamic clot lysis using plasmin or rt-PA in an in vitro flow system.
Bizjak N; Bajd F; Vidmar J; Blinc A; Perme MP; Marder VJ; Novokhatny V; Serša I
Thromb Res; 2014 May; 133(5):908-13. PubMed ID: 24613694
[TBL] [Abstract][Full Text] [Related]
3. Resistance of porcine blood clots to lysis relates to poor activation of porcine plasminogen by tissue plasminogen activator.
Flight SM; Masci PP; Lavin MF; Gaffney PJ
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):417-20. PubMed ID: 16788320
[TBL] [Abstract][Full Text] [Related]
4. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
[TBL] [Abstract][Full Text] [Related]
5. Cross-linking of alpha 2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences.
van Giezen JJ; Minkema J; Bouma BN; Jansen JW
Blood Coagul Fibrinolysis; 1993 Dec; 4(6):869-75. PubMed ID: 7511944
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.
Schaefer AV; Leslie BA; Rischke JA; Stafford AR; Fredenburgh JC; Weitz JI
Biochemistry; 2006 Apr; 45(13):4257-65. PubMed ID: 16566600
[TBL] [Abstract][Full Text] [Related]
7. A reconstituted dilute blood clot lysis assay for the medium throughput screening of thrombolytic compounds.
Gadbut AP; Schullek JR; Hanel AM; MacAllan DR
Anal Biochem; 1999 May; 270(1):24-32. PubMed ID: 10328761
[TBL] [Abstract][Full Text] [Related]
8. Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro.
Korninger C; Collen D
Thromb Haemost; 1981 Aug; 46(2):561-5. PubMed ID: 6795744
[TBL] [Abstract][Full Text] [Related]
9. Locally applied recombinant plasmin results in effective thrombolysis in a porcine model of arteriovenous graft thrombosis.
Hoefer IE; Stroes ES; Pasterkamp G; Levi MM; Reekers JA; Verhagen HJ; Meijers JC; Humphries JE; Rotmans JI
J Vasc Interv Radiol; 2009 Jul; 20(7):951-8. PubMed ID: 19481472
[TBL] [Abstract][Full Text] [Related]
10. An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activator.
Wootton DM; Popel AS; Alevriadou BR
Biotechnol Bioeng; 2002 Feb; 77(4):405-19. PubMed ID: 11787013
[TBL] [Abstract][Full Text] [Related]
11. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
[TBL] [Abstract][Full Text] [Related]
12. Tridegin, a novel peptidic inhibitor of factor XIIIa from the leech, Haementeria ghilianii, enhances fibrinolysis in vitro.
Seale L; Finney S; Sawyer RT; Wallis RB
Thromb Haemost; 1997 May; 77(5):959-63. PubMed ID: 9184410
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis.
Dupe RJ; English PD; Smith RA; Green J
Thromb Haemost; 1981 Aug; 46(2):528-34. PubMed ID: 6458112
[TBL] [Abstract][Full Text] [Related]
14. Transport phenomena and clot dissolving therapy: an experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis.
Wu JH; Siddiqui K; Diamond SL
Thromb Haemost; 1994 Jul; 72(1):105-12. PubMed ID: 7974357
[TBL] [Abstract][Full Text] [Related]
15. Role of plasminogen, plasmin, and plasminogen activators in the migration of fibroblasts into plasma clots.
Knox P; Crooks S; Scaife MC; Patel S
J Cell Physiol; 1987 Sep; 132(3):501-8. PubMed ID: 2958486
[TBL] [Abstract][Full Text] [Related]
16. Influence of homocysteine on fibrin network lysis.
Lauricella AM; Quintana I; Castañon M; Sassetti B; Kordich L
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):181-6. PubMed ID: 16575255
[TBL] [Abstract][Full Text] [Related]
17. Comparison of local thrombolytic efficacy of plasmin and rt-PA in an in-vitro flow system; a pilot study.
Bizjak N; Bajd F; Vidmar J; Blinc A; Marder VJ; Novokhatny V; Serša I
Blood Coagul Fibrinolysis; 2013 Oct; 24(7):711-4. PubMed ID: 23751605
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and biophysical conditions for blood clot lysis.
Sabovic M; Blinc A
Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642
[TBL] [Abstract][Full Text] [Related]
19. Properties of thrombolytic agents in vitro using a perfusion circuit attaining shear stress at physiological levels.
Nishino N; Scully MF; Rampling MW; Kakkar VV
Thromb Haemost; 1990 Dec; 64(4):550-5. PubMed ID: 2128138
[TBL] [Abstract][Full Text] [Related]
20. Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin.
Hunt JA; Petteway SR; Scuderi P; Novokhatny V
Thromb Haemost; 2008 Sep; 100(3):413-9. PubMed ID: 18766256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
